1. A potential role for CCN2/CTGF in aggressive colorectal cancer
   Inge Ubink et al, 2016, Journal of Cell Communication and Signaling CrossRef
2. α‐enolase promotes tumorigenesis and metastasis via regulating AMPK/mTOR pathway in colorectal cancer
   Panpan Zhan et al, 2017, Molecular Carcinogenesis CrossRef
3. The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer
   Diana J. Uribe et al, 2017, PLOS ONE CrossRef
4. YAP/TAZ Signalling in Colorectal Cancer: Lessons from Consensus Molecular Subtypes
   Sophie Mouillet-Richard et al, 2020, Cancers CrossRef
5. Oncogenic Role of Connective Tissue Growth Factor Is Associated with Canonical TGF-β Cascade in Colorectal Cancer
   Shaghayegh Hosseini et al, 2022, Genes CrossRef
6. Electrochemical immunosensor for receptor tyrosine kinase AXL using poly(pyrrolepropionic acid)-modified disposable electrodes
   V. Serafín et al, 2017, Sensors and Actuators B: Chemical CrossRef
7. Tafazzin (TAZ) promotes the tumorigenicity of cervical cancer cells and inhibits apoptosis
   Mei Chen et al, 2017, PLOS ONE CrossRef
8. Spatiotemporal Loss of NF1 in Schwann Cell Lineage Leads to Different Types of Cutaneous Neurofibroma Susceptible to Modification by the Hippo Pathway
   Zhiguo Chen et al, 2019, Cancer Discovery CrossRef
9. Targeting CTGF in Cancer: An Emerging Therapeutic Opportunity
   Yi-Wen Shen et al, 2021, Trends in Cancer CrossRef
10. Colon cancer subtypes: concordance, effect on survival and selection of the most representative preclinical models
    Zsófia Sztupinszki et al, 2016, Scientific Reports CrossRef
11. The Hippo Pathway Effector Transcriptional Co-activator With PDZ-Binding Motif Correlates With Clinical Prognosis and Immune Infiltration in Colorectal Cancer
    Yutong Wang et al, 2022, Frontiers in Medicine CrossRef
12. Role of AXL in invasion and drug resistance of colon and breast cancer cells and its association with p53 alterations
    Wael M Abdel-Rahman et al, 2017, World Journal of Gastroenterology CrossRef